ES2140511T3 - Procedimiento para separar y medir glicoproteinas. - Google Patents

Procedimiento para separar y medir glicoproteinas.

Info

Publication number
ES2140511T3
ES2140511T3 ES94308314T ES94308314T ES2140511T3 ES 2140511 T3 ES2140511 T3 ES 2140511T3 ES 94308314 T ES94308314 T ES 94308314T ES 94308314 T ES94308314 T ES 94308314T ES 2140511 T3 ES2140511 T3 ES 2140511T3
Authority
ES
Spain
Prior art keywords
glucoprotein
analysis
substances
linked
measured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94308314T
Other languages
English (en)
Inventor
Hideo Katoh
Kenji Nakamura
Shinji Satomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chemical Industries Ltd filed Critical Wako Pure Chemical Industries Ltd
Application granted granted Critical
Publication of ES2140511T3 publication Critical patent/ES2140511T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5756—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumour-associated glycolinkage [TAG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5757—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofoetal proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

EL ALCANCE DE UN CAMBIO EN LA ESTRUCTURA DE LA CADENA DE AZUCAR DE UNA GLUCOPROTEINA PROVOCADO POR UNA ENFERMEDAD SE PUEDE MEDIR RAPIDAMENTE Y CON GRAN PRECISION SI SE SEPARAN Y SE MIDEN DOS O MAS FORMAS DE GLUCOPROTEINAS QUE TIENEN UNA ESTRUCTURA DE LA CADENA DE AZUCAR DIFERENTE QUE PERO QUE TIENEN SUSTANCIALMENTE LA MISMA ESTRUCTURA DE LA PROTEINA, MEDIANTE LA UTILIZACION DE UNA COMBINACION DE UNA LECTINA CAPAZ DE RECONOCER LA ESTRUCTURA DE LA CADENA DE AZUCAR ESPECIFICA DE AL MENOS UNA DE ESTAS SUSTANCIAS DE ANALISIS DE GLUCOPROTEINAS A MEDIR Y UN PRIMER ANTICUERPO QUE SE PUEDE ENLAZAR A TODAS LAS SUSTANCIAS DE ANALISIS DE GLUCOPROTEINAS PERO NO SE ENLAZA A LA O LAS SUSTANCIAS DE ANALISIS DE GLUCOPROTEINAS QUE TIENEN LA LECTINA UNIDA A LAS MISMAS; Y SI SE SEPARAN Y SE MIDEN LA O LAS SUSTANCIAS DE ANALISIS DE GLUCOPROTEINAS QUE TIENEN EL PRIMER ANTICUERPO UNIDO A LAS MISMAS Y LA O LAS SUSTANCIAS DE ANALISIS QUE NO TIENEN EL PRIMER ANTICUERPO UNIDO A LAS MISMAS, MEDIANTE LA UTILIZACION DELAS DIFERENCIAS DE LAS PROPIEDADES ENTRE LA O LAS SUSTANCIAS DE ANALISIS DE GLUCOPROTEINAS PRIMERAS Y LA O LAS SUSTANCIAS DE ANALISIS DE GLUCOPROTEINAS ULTIMAS.
ES94308314T 1993-11-16 1994-11-10 Procedimiento para separar y medir glicoproteinas. Expired - Lifetime ES2140511T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30983993 1993-11-16

Publications (1)

Publication Number Publication Date
ES2140511T3 true ES2140511T3 (es) 2000-03-01

Family

ID=17997899

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94308314T Expired - Lifetime ES2140511T3 (es) 1993-11-16 1994-11-10 Procedimiento para separar y medir glicoproteinas.

Country Status (6)

Country Link
US (1) US5591589A (es)
EP (1) EP0653640B1 (es)
KR (1) KR100231628B1 (es)
DE (1) DE69422692T2 (es)
ES (1) ES2140511T3 (es)
TW (1) TW380204B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0441470B1 (en) * 1990-01-09 1995-12-20 Wako Pure Chemical Industries Ltd Process for separating and measuring trace components
US5630924A (en) 1995-04-20 1997-05-20 Perseptive Biosystems, Inc. Compositions, methods and apparatus for ultrafast electroseparation analysis
US6677123B1 (en) * 1998-02-03 2004-01-13 Wako Pure Chemical Industries, Ltd. Process for detecting increased risk of fetal chromosomal abnormality
EP0973038B1 (en) * 1998-06-30 2006-08-23 Wako Pure Chemical Industries, Ltd. Method for measuring thyroglobulin
EP1376126B1 (en) * 2001-04-04 2010-05-05 Wako Pure Chemical Industries, Ltd. Electrophoresis with double-stranded dna marker
JPWO2002101389A1 (ja) * 2001-06-12 2005-04-07 和光純薬工業株式会社 ヒアルロン酸の測定方法
GB0212391D0 (en) * 2002-05-29 2002-07-10 Axis Shield Asa Assay
DE10249608A1 (de) * 2002-10-18 2004-05-06 Gkss-Forschungszentrum Geesthacht Gmbh Vorrichtung und Verfahren zur Strukturanalyse und Detektion von komplexen Glykostrukturen
ITTO20070455A1 (it) * 2007-06-25 2008-12-26 Univ Pisa Procedimento di determinazione e di separazione di isoforme di gamma-glutamiltransferasi (ggt) sierica in un campione di fluido biologico e isoforme enzimatiche cosi' ottenute
KR101534063B1 (ko) 2008-12-09 2015-07-07 삼성전자주식회사 업라이트 및 캐니스터 겸용 진공청소기
EP2843412B1 (en) * 2012-04-27 2018-01-03 Konica Minolta, Inc. Antigen detection method which uses lectin and comprises enzyme treatment step
WO2014025013A1 (ja) * 2012-08-10 2014-02-13 独立行政法人産業技術総合研究所 糖鎖アイソフォーム検出方法及び糖鎖アイソフォーム検出装置
CN103674918A (zh) * 2013-12-12 2014-03-26 复旦大学 一种基于凝集素液相悬浮芯片检测糖蛋白糖链结构的方法
JP6323463B2 (ja) 2013-12-27 2018-05-16 コニカミノルタ株式会社 診断用情報の分析方法およびそのためのキット
US10371704B2 (en) 2013-12-27 2019-08-06 Konica Minolta, Inc. Method for discriminating between prostate cancer and a benign prostate disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate
GB2043890B (en) * 1979-01-30 1983-09-07 Otsuka Pharma Co Ltd Determination of tumour associated glycolinkage and diagnosis of cancer
JPH0734015B2 (ja) * 1988-04-25 1995-04-12 和光純薬工業株式会社 微量成分の新規測定法
JPH0373852A (ja) * 1989-05-24 1991-03-28 Eiji Ishikawa 特異的糖鎖を有する物質の測定法
EP0441470B1 (en) * 1990-01-09 1995-12-20 Wako Pure Chemical Industries Ltd Process for separating and measuring trace components

Also Published As

Publication number Publication date
TW380204B (en) 2000-01-21
EP0653640A1 (en) 1995-05-17
EP0653640B1 (en) 2000-01-19
KR100231628B1 (ko) 1999-11-15
DE69422692T2 (de) 2000-07-06
KR950014136A (ko) 1995-06-15
US5591589A (en) 1997-01-07
DE69422692D1 (de) 2000-02-24

Similar Documents

Publication Publication Date Title
AR031557A1 (es) Sonda optica y metodos para analisis espectral.
ES2128362T3 (es) Fragmentos de proteinas de prion.
ES507948A0 (es) Procedimiento y dispositivo de analisis simultaneo, especialmente para analisis clinicos. otrosi.
ES2032802T3 (es) Sucedaneo de la sangre, semisintetico, extrapuro.
ES2162621T3 (es) Dispositivo y procedimiento para detectar analitos.
AR002076A1 (es) Dispositivo para la inspeccion de un fluido, particularmente en analisis hematologicos.
ES2097747T3 (es) Molecula de adhesion intercelular 2 y sus ligandos de union.
BR112022011312A2 (pt) Análise de um analito disposto dentro de um meio
AR013671A1 (es) Dispositivo de ensayo para la determinacion de substancias a analizar en un producto dietario liquido, procedimiento para la deteccion de substancias a analizar en un producto dietario y kit de ensayo que comprende dicho dispositivo
ES2184395T3 (es) Reactivo para medir la hemoglobina y determinar los leucocitos en una muestra de sangre.
FI900644A7 (fi) Uuttokoostumus, testipakkaus ja niiden käyttö Herpes simplex -viruksen antigeenin uuttamiseksi tai määrittämiseksi
MX2022005143A (es) Sistemas de ensayo de flujo lateral y métodos para la cuantificación de una muestra biológica.
IT1113502B (it) Procedimento per la stabilizzazione di composti,particolarmente di antibiotici impiegati negli esami biologici,e dispositivo ottenuto con il procedimento
ES2047874T3 (es) Captador de membrana con concentracion de deformaciones.
ES2053712T3 (es) Un antigeno proteico reactivo y fragmentos del mismo.
ECSP034743A (es) Peptidos a partir del anticuerpo 16/61d para tratar lupus eritematoso sistemico
DE60223040D1 (de) Epitop-untersuchung mit hla
FI973184A0 (fi) Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibiittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdollisesti yhdessä AZT:n, DDI:n tai DDC:n kanssa
ES2185652T3 (es) Oligopeptidos derivados de fragmentos de proteinas c-reactiva.
ES2082429T3 (es) Metodo de deteccion inmunologico.
ES2110558T3 (es) Metodo y aparato para determinar la distribucion de cordones en bandajes.
AR224900A1 (es) Un conjunto de ensayo u.v.cinetico para la determinacion simultanea de transaminasa glutamica oxalacetica(got)y transaminasa glutamica piruvica(gpt)en una sola muestra de suero o plasma
BRPI0500628A (pt) Dispositivo para medição de ângulo e processo para sua fabricação
ES2022696B3 (es) Dispositivo de ensamblaje de dos caballetes entre si, al nivel de la viga maestra, para la realizacion de armazones y estructuras.
ITBO980239A0 (it) Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 653640

Country of ref document: ES